4575.T
Price:
$819
Market Cap:
$16.14B
CanBas Co., Ltd., a clinical stage biopharmaceutical company, develops therapeutics for cancer patients. It develops CBP501, a calmodulin-modulating peptide to treat various cancer; and CBS9106, a reversible exportin-1inhibitor that is in Phase I clinical trial for the treatment of solid tumors. The company has a collaboration alliance with Stemline Therapeutics, Inc. CanBas Co., Ltd. was incorporated in 2000 and is based in Numazu, Japan.
Industry
Biotechnology
IPO Date
2009-09-17
Stock Exchange
JPX
Ticker
4575.T
According to CanBas Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.67B. This represents a change of -21.11% compared to the average of 17.33B of the last 4 quarters.
The mean historical Enterprise Value of CanBas Co., Ltd. over the last ten years is 5.85B. The current 13.67B Enterprise Value has changed 23.25% with respect to the historical average. Over the past ten years (40 quarters), 4575.T's Enterprise Value was at its highest in in the March 2023 quarter at 22.42B. The Enterprise Value was at its lowest in in the December 2015 quarter at 0.
Average
5.85B
Median
3.68B
Minimum
0
Maximum
19.80B
Discovering the peaks and valleys of CanBas Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 19.80B
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 0
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 19.80B | 129.22% |
| 2024 | 8.64B | -48.61% |
| 2023 | 16.81B | 184.15% |
| 2022 | 5.92B | 124.41% |
| 2021 | 2.64B | -44.21% |
| 2020 | 4.73B | Infinity% |
| 2019 | 0 | 0% |
| 2018 | 0 | 0% |
| 2017 | 0 | 0% |
| 2016 | 0 | 0% |
The current Enterprise Value of CanBas Co., Ltd. (4575.T) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
15.09B
5-year avg
10.76B
10-year avg
5.85B
CanBas Co., Ltd.’s Enterprise Value is greater than StemRIM (9.16B), less than Oncolys BioPharma Inc. (25.35B), greater than CellSeed Inc. (7.43B), greater than ReproCELL Incorporated (11.31B), less than RaQualia Pharma Inc. (29.12B), less than Medical Data Vision Co., Ltd. (15.58B), less than Japan Tissue Engineering Co., Ltd. (15.65B), greater than NANO MRNA Co.,Ltd. (9.37B), less than Sunwels Co.,Ltd. (36.76B), greater than MediciNova, Inc. (41.81M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 9.16B | $16.16B | |
| 25.35B | $26.36B | |
| 7.43B | $8.67B | |
| 11.31B | $14.01B | |
| 29.12B | $29.62B | |
| 15.58B | $17.41B | |
| 15.65B | $19.57B | |
| 9.37B | $10.33B | |
| 36.76B | $11.97B | |
| 41.81M | $11.67B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CanBas Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CanBas Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CanBas Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for CanBas Co., Ltd. (4575.T)?
What is the 3-year average Enterprise Value for CanBas Co., Ltd. (4575.T)?
What is the 5-year average Enterprise Value for CanBas Co., Ltd. (4575.T)?
How does the current Enterprise Value for CanBas Co., Ltd. (4575.T) compare to its historical average?